139 related articles for article (PubMed ID: 37838358)
1. Management of Cholinergic Rebound After Abrupt Withdrawal of Clozapine: A Case Report and Systematic Literature Review.
Bickerton L; Kuriakose JL
J Acad Consult Liaison Psychiatry; 2024; 65(1):76-88. PubMed ID: 37838358
[TBL] [Abstract][Full Text] [Related]
2. A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder.
Galova A; Berney P; Desmeules J; Sergentanis I; Besson M
BMC Psychiatry; 2019 Feb; 19(1):73. PubMed ID: 30782143
[TBL] [Abstract][Full Text] [Related]
3. Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review.
Yee B; Looi JCL; Agaciak M; Allison S; Chan SKW; Bastiampillai T
East Asian Arch Psychiatry; 2023 Jun; 33(2):44-64. PubMed ID: 37400227
[TBL] [Abstract][Full Text] [Related]
4. Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report.
Yeh AW; Lee JW; Cheng TC; Wen JK; Chen WH
Clin Neuropharmacol; 2004; 27(5):216-8. PubMed ID: 15602101
[TBL] [Abstract][Full Text] [Related]
5. Rebound insomnia after abrupt clozapine withdrawal.
Staedt J; Stoppe G; Hajak G; Ruther E
Eur Arch Psychiatry Clin Neurosci; 1996; 246(2):79-82. PubMed ID: 9063912
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal.
Shiovitz TM; Welke TL; Tigel PD; Anand R; Hartman RD; Sramek JJ; Kurtz NM; Cutler NR
Schizophr Bull; 1996; 22(4):591-5. PubMed ID: 8938913
[TBL] [Abstract][Full Text] [Related]
7. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series.
Ahmed S; Chengappa KN; Naidu VR; Baker RW; Parepally H; Schooler NR
J Clin Psychiatry; 1998 Sep; 59(9):472-7. PubMed ID: 9771818
[TBL] [Abstract][Full Text] [Related]
8. Clozapine-withdrawal catatonia.
Wadekar M; Syed S
Psychosomatics; 2010; 51(4):355-355.e2. PubMed ID: 20587767
[TBL] [Abstract][Full Text] [Related]
9. Effect of anticholinergics in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal.
Seppälä N; Kovio C; Leinonen E
CNS Drugs; 2005; 19(12):1049-55. PubMed ID: 16332145
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal from clozapine: the "rebound phenomenon".
Durst R; Teitelbaum A; Katz G; Knobler HY
Isr J Psychiatry Relat Sci; 1999; 36(2):122-8. PubMed ID: 10472746
[TBL] [Abstract][Full Text] [Related]
11. [Reversible catatonia after the abrupt discontinuation of clozapine: Case report].
Jaafari M; Bout A; Rammouz I; Aalouane R
Encephale; 2016 Dec; 42(6):580-581. PubMed ID: 27644914
[TBL] [Abstract][Full Text] [Related]
12. [No rebound psychosis in a case of switching from clozapine to quetiapine].
Walther S; Baciu D
Psychiatr Prax; 2006 Mar; 33(2):93-4. PubMed ID: 16502388
[TBL] [Abstract][Full Text] [Related]
13. Clozapine Discontinuation and Malignant Catatonia: A Case Report.
Kapulsky L; Greiner MG; Daniels JE; Gordon-Elliott JS
Psychosomatics; 2019; 60(1):75-79. PubMed ID: 29703551
[No Abstract] [Full Text] [Related]
14. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases.
Stanilla JK; de Leon J; Simpson GM
J Clin Psychiatry; 1997 Jun; 58(6):252-5. PubMed ID: 9228890
[TBL] [Abstract][Full Text] [Related]
15. [Clozapine withdrawal. A review].
Szafrański T; Gmurkowski K
Psychiatr Pol; 1999; 33(1):51-67. PubMed ID: 10786215
[TBL] [Abstract][Full Text] [Related]
16. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group.
Tollefson GD; Dellva MA; Mattler CA; Kane JM; Wirshing DA; Kinon BJ
J Clin Psychopharmacol; 1999 Oct; 19(5):435-43. PubMed ID: 10505585
[TBL] [Abstract][Full Text] [Related]
17. A systematic review on the use of clozapine in treatment of tardive dyskinesia and tardive dystonia in patients with psychiatric disorders.
Wong J; Pang T; Cheuk NKW; Liao Y; Bastiampillai T; Chan SKW
Psychopharmacology (Berl); 2022 Nov; 239(11):3393-3420. PubMed ID: 36180741
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome after neuroleptic discontinuation.
Amore M; Zazzeri N
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-olanzapine: a potentially dangerous switch. A report of two cases.
Delassus-Guenault N; Jegouzo A; Odou P; Seguret T; Zangerlin H; Vignole E; Robert H
J Clin Pharm Ther; 1999 Jun; 24(3):191-5. PubMed ID: 10438178
[TBL] [Abstract][Full Text] [Related]
20. Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review.
Pardis P; Remington G; Panda R; Lemez M; Agid O
J Psychopharmacol; 2019 Oct; 33(10):1187-1198. PubMed ID: 31347436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
